What researchers published on Akut limfoid leukémia (ALL)
2155 papers, newest first.
Showing 20 of 2155
Not labelled yetLocally manufactured point-of-care CD19 chimeric antigen receptor T-cell therapy for paediatric relapsed/refractory B-cell acute lymphoblastic leukaemia: a single-centre feasibility experience.Frontiers in oncology
Not labelled yetThe genetic profile of B-cell acute lymphoblastic leukaemia diagnosed in Pretoria, South Africa: A 10-year retrospective study.Journal of the colleges of medicine of South Africa
Not labelled yetInternational Cross-Age Consensus Guideline on Measurable Residual Disease Assessment in Acute Lymphoblastic Leukemia.Blood
Not labelled yetA clinical prediction model for sepsis in chemotherapy-induced neutropenia among children with acute lymphoblastic leukemia: development and validation.BMC pediatrics
Not labelled yetDasatinib, prednisolone, and vincristine as a 'chemo-lite' induction approach for Philadelphia chromosome-positive acute lymphoblastic leukemia.Leukemia & lymphoma
Not labelled yetResponse to venetoclax-containing regimens in patients with relapsed/refractory (R/R) T-cell acute lymphoblastic leukaemia (T-ALL) and lymphoblastic lymphoma (T-LBL).British journal of haematology
Not labelled yetOutcomes of haploidentical stem cell transplantation in pediatric Philadelphia chromosome-like B-cell acute lymphoblastic leukemia in the era of immunotherapy.Leukemia & lymphoma
ÁttekintésSteroid-Related Neuropsychiatric Symptoms (SRNS) in Children with Acute Lymphoblastic Leukemia (ALL): A Systematic Review of Clinical Features, Risk Factors, and Management.Cancer management and research
Vizsgálati eredményIndividualizing Apheresis Processing Volumes Using a Predictive Algorithm: Analysis of the CAR T-Cell Collection Protocol Utilized in ACIT001/EXC002, a Phase Ib/II Trial of Decentralized Production of CAR T Cells for Treatment of Relapsed/Refractory Aggressive NHL and ALL.Journal of clinical apheresis
Áttekintés[Treatment strategies for acute lymphoblastic leukemia in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
PreprintNHE1 sustains leukemia-propagating capacity and mitochondrial fitness in T-cell acute lymphoblastic leukemia.bioRxiv : the preprint server for biology
Not labelled yetStage 0 hematogones essentially lack CD9 expression: comparative immunophenotypic analysis of hematogone subsets and myeloid blasts.American journal of clinical pathology
Not labelled yetDynamic Radiologic Severity Index is associated with antifungal treatment but does not independently predict initiation in pediatric acute lymphoblastic leukemia with post-chemotherapy pneumonia.Translational pediatrics
Not labelled yetReal-world efficacy and safety of blinatumomab across three clinical settings in pediatric B-cell acute lymphoblastic leukemia: a single-center retrospective cohort study.Translational cancer research
PreprintABCB1-Mediated Drug Efflux Drives Resistance to VpreB1-Targeted Antibody-Drug Conjugates in B-cell Lymphoblastic Leukemia.Research square
Not labelled yetClinical outcomes of T-cell acute lymphoblastic leukemia versus T-cell lymphoblastic lymphoma after allogeneic hematopoietic stem cell transplantation.Annals of hematology
Not labelled yetSecond Allogeneic Hematopoietic Cell Transplantation for Post-Transplant Relapsed Acute Lymphoblastic Leukemia: Outcomes, Competing Risks, and the Impact of Bridging Salvage Therapy.Clinical lymphoma, myeloma & leukemia
EsetismertetésAssay-aware flow-cytometric interpretation of relapsed B-cell precursor acute lymphoblastic leukemia after sequential CD19- and CD22-directed therapy: A case report.Medicine
EsetismertetésCase Report: Diagnostic and management challenges of necrotizing fasciitis in an immunocompromised child with acute lymphoblastic leukaemia.Frontiers in surgery
Not labelled yetTolvaptan in the treatment of SIADH-associated hyponatremia in acute lymphoblastic leukemia and lymphoblastic lymphoma: a retrospective study.Pediatric hematology and oncology